Status:
COMPLETED
Comparing Highly Purified hMG With Recombinant FSH + Recombinant LH in Women Undergoing Intrauterine Insemination.
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Conditions:
Ovarian Stimulation Preceding Intrauterine Insemination
Eligibility:
FEMALE
18-39 years
Phase:
PHASE4
Brief Summary
The present study aims to elucidate if the FSH and LH activity contained in hMG preparations is comparable to the recombinant FSH and LH administration in a 1:1 ratio. The mean outcome is the correspo...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Esterility \> 1 year duration
- \< 39 years old
- REM \> 3 millions/ml
- 1 or 2º IUI cycle
- Exclusion criteria:
- Ovarian policystic syndrome
- Severe Endometriosis
- Uterine disease (polyps, myomas, intracavitarios, malformations…)
Exclusion
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00820482
Start Date
January 1 2009
End Date
May 1 2009
Last Update
September 18 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI Valencia
Valencia, Valencia, Spain, 46117
2
IVI Valencia
Valencia, Valencia, Spain, 4